Infectious Disease Diagnostics Market Overview
In 2022, the infectious disease diagnostics market is anticipated to be worth US$ 1.47 billion in terms of revenue. The market is projected to expand at a CAGR of 7% to reach a size of US$ 3.48 billion by 2032.
The first and most crucial stage in identifying an illness and treating it is the diagnosis, and continual advancements in science are transforming the practice of doing quick diagnostics. During the forecast period, ongoing technological breakthroughs will continue to alter the industrial environment. Intending to raise awareness, properly diagnose illnesses, and reduce the risk of infection, several government-funded initiatives are progressively offering free screening and testing all around the world. During the forecast period, these activities are expected to accelerate the infectious disease diagnostics market expansion.
Important market-expanding factors include the increased frequency of infectious diseases, the change in emphasis from centralized laboratories to point-of-care testing, and increasing research and development investment in infectious disease diagnostics. As a result of scientific research and development efforts to create breakthrough technologies and techniques like mass spectrometry and next-generation sequencing (NGS), which are supporting the expansion of the infectious disease diagnostics market, rapid diagnostics for the identification of illnesses are evolving.
The creation of point-of-care assays is highly prioritized for the diagnosis of numerous infectious diseases. Point-of-care diagnostics give quicker findings because no sample needs to be transported to a diagnostic lab. The need for point-of-care testing is anticipated to increase as a result of this reason. Businesses are putting their efforts into creating analytical systems that deliver data from molecular assays close to the patient.
In order to expand infectious disease diagnostics across healthcare settings, several businesses are investing heavily. Thus, it is anticipated that the aforementioned factors will fuel market expansion in the years to come. The prevalence of chronic diseases worldwide is expected to increase, which will fuel the need for early diagnostic tests and boost market expansion. The launch of technologically advanced products by major rivals is also projected to speed up the infectious disease diagnostics market growth. This includes new research and developments, technical improvements, and other factors. BD declared the arrival of its brand-new, fully automated, high-throughput infectious disease diagnostics platform in the US in May 2022.
The inclination of end users for point-of-care testing is another factor anticipated to drive market growth. In the exact location where the disease is being experienced, point-of-care diagnostics provide rapid, helpful information for patient care. As a result, several large companies are focusing on R&D projects to offer point-of-care diagnostic solutions for developing countries. The key companies are continually upgrading their product lines via the launch of new products, joint ventures with other businesses, mergers, and acquisitions, all of which will support the growth of the global study market. In countries that accept the CE certification, Roche will roll out the first infectious disease tests on the Cobas 5800 System in December 2021.
Businesses involved in disease diagnostic technologies are concentrating on the creation of innovative diagnostics, which will eventually accelerate market growth. Additionally, there is a high need for diagnostics for infectious diseases due to the increased frequency of malaria, the flu, AIDS, and other illnesses. Infectious disease diagnostic kits are more likely to acquire momentum throughout the projection period as more doctors switch to evidence-based treatment strategies.
Infectious Disease Diagnostics Market CAGR
Infectious Disease Diagnostics Market (2022)
US$ 1.47 Billion
Infectious Disease Diagnostics Market (2032)
US$ 3.48 Billion
Infectious disease diagnostics is process of identifying the presence of foreign antigen/organism with the help of various diagnostic tools. Infectious disease conditions are highly prevalent in under developed regions due to lack of awareness for personal hygiene, minimal healthcare expenditures and absence of efficient physician services.
The high incidence of infectious diseases across emerging economies formulate a major share in overall market. This has grab the attention of in vitro diagnostic device manufactures to invest into emerging economies. These companies are taking efforts to develop and commercialize cost effective tools for the infectious disease diagnosis. Presently, the gold standard tests available for bacterial infections and sexually transmitted disease diagnosis have major market share. However, these test are expected to replace by molecular techniques in future.
Infectious Disease Diagnostics Market: Drivers and Restraints
Increasing incidence of infectious disease, growing adoption of advanced molecular techniques, and increasing interventions from government and non-profile organization to reduce infectious disease in underdeveloped regions are endorsing the growth of infectious disease diagnosis market.
In addition, the companies operating in the disease diagnostic technologies are focusing on the development of novel diagnostics, which eventually provides pace to the market growth. However, lack of awareness for novel diagnostic solution, absence of compiled regulatory guidelines and lower positivity rates due to inferior laboratory conditions would hinder the growth of infectious disease diagnostics market.
Infectious Disease Diagnostics Market: Overview
By test type, the laboratory tests hold prominent share owing to its lower cost and easy availability. The emerging economies are the prime contributors of laboratory test segment especially in Asia-Pacific region, owing to high positivity rates. Laboratory test are first line of diagnostics referred by physicians which includes, blood test, urine test, spinal tap, throat swabs, and stool test.
By techniques, the molecular diagnostic techniques such as PCR, and other nucleic acid amplification test would gain prominence in developed region. Based on condition, the bacterial infections, GI infections and Sexually transmitted disease have the largest share in infectious disease testing market, owing to high prevalence especially in emerging economies.
Infectious Disease Diagnostics Market: Region-wise Outlook
Emerging economies such as India and China are the primary consumer for infection disease testing market, owing to growing urbanization which leads to unhygienic environment in the cities. Countries belongs to Asia-Pacific and Africa regions have largest share in infectious disease diagnosis market due to high prevalence and incidence of infectious diseases especially sexually transmitted disease and bacterial infections.
North America and European countries will ahead towards the adoption on high end infectious disease diagnostic with the help of molecular technologies. This increasing adoption of premium diagnostic techniques would sustain the market share of infectious disease diagnostics in developed region.
Infectious Disease Diagnostics Market: Key Players
Key companies operational in infectious diseases testing market are Becton Dickinson & Company, Cepheid Inc., Abbott Laboratories, BioMerieux, Hologic Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Affymetrix, Alere Inc., and DiaSorin. These companies are majorly focusing on getting approval for the commercialiation of their novel product launch. Recently, in 2015, Bio-Rad Laboratories, Inc. has got approval from US FDA for its BioPlex 2200 HIV Ag-Ab assay, which is used for HIV antigens and HIV antibodies.
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies involved
- Value Chain
Regional analysis includes
- North America (U.S., Canada)
- Latin America (Mexico, Brazil)
- Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
- Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
- Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Infectious Disease Diagnostics Market: Segmentation
The global infectious disease diagnostics market is segmented based on, test type, techniques, application, and end users.
Based on test type, the global infectious disease diagnostics market is segmented into the following:
- Laboratory tests
- Blood test
- Urine test
- Spinal tap
- Throat swabs
- Stool test
- Imaging test
- Computed tomography (CT)
- Magnetic Resonance Imaging (MRI)
Based on techniques, the global infectious disease diagnostics market is segmented into the following:
- Conventional techniques
- Pathogen culturing
- Biochemical techniques
- Enzyme immunoassay
- Molecular techniques
- Nucleic acid sequence based amplification
Based on condition, the global infectious disease diagnostics market is segmented into the following:
- Bacterial Infection
- Viral Infection
- CNS infections
- Cardiovascular infection
- Fungal infection
- GI infections
- Sexually transmitted disease
Based on end use, the global infectious disease diagnostics market is segmented into the following:
- Diagnostic laboratories
- Academic and medical institutes
- Contract Research Organization
- Hospitals and Surgical centers
- Ambulatory clinics
- Home healthcare